サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1159363

人工涙液の世界市場（2022年～2028年）

Artificial Tears Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 125 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
人工涙液の世界市場（2022年～2028年）
出版日: 2022年10月18日
発行: Orion Market Research
ページ情報: 英文 125 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工涙液の市場規模は、予測期間中に6.2%の大幅なCAGRで成長すると予測されています。市場の成長を後押しする主な要因には、ドライアイ症候群の発生率の増加などが挙げられます。

当レポートでは、世界の人工涙液市場を調査しており、市場の概要、市場動向の分析、タイプ別・提供方法別・用途別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と見解

  • 調査範囲
  • アナリストの見解と現在の市場動向

第3章 競合情勢

  • 主要企業分析
  • Bausch Health Companies Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Bayer Pharma AG
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Bayer Pharma AG
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Johnson & Johnson Services
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Teva Pharmaceuticals Industries, Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • 主要戦略分析
  • 主要企業へのCOVID-19の影響

第4章 市場セグメンテーション

  • 世界の人工涙液市場：タイプ別
    • セルロース由来
    • グリセリン由来
    • 油性エマルジョン涙液
    • ポリエチレングリコール・プロピレングリコールベース涙液
  • 世界の人工涙液市場：提供方法別
    • 目薬
    • 軟膏
  • 世界の人工涙液市場：用途別
    • ドライアイ治療
    • コンタクトレンズの水分

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Allergan Plc
  • Aura Labs Ltd.
  • Bausch Health Companies Inc.
  • Bausch & Lomb Inc.
  • Carl Zeiss AG
  • Essilor International
  • Hoya Corp.
  • Nicox S.A.
  • Novartis International AG
  • OCuSOFT Inc.
  • Pfizer, Inc.
  • ROHTO Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Santen AG
  • Similasan Corp.
  • Topcon Corp.
  • URSAPHARM Arzneimittel GmbH
図表

LIST OF TABLES

  • 1. GLOBAL ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL CELLULOSE DERIVED ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL GLYCERINE DERIVED MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL WILM'S TUMOUR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL OTHER ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2021-2028 ($ MILLION)
  • 7. GLOBAL EYE DROPS ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL OINTMENTS ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL OTHER ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ARTIFICIAL TEARS DRY EYES TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL ARTIFICIAL TEARS CONTACT LENSES MOISTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL ARTIFICIAL TEARS MAGNETIC RESONANCE IMAGING (MRI) SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL ARTIFICIAL TEARS ULTRASOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2021-2028 ($ MILLION)
  • 16. GLOBAL ARTIFICIAL TEARS IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. GLOBAL ARTIFICIAL TEARS CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 18. GLOBAL ARTIFICIAL TEARS RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 19. GLOBAL ARTIFICIAL TEARS CRYOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 20. GLOBAL ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. NORTH AMERICAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY TYPE , 2021-2028 ($ MILLION)
  • 23. NORTH AMERICAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2021-2028 ($ MILLION)
  • 24. NORTH AMERICAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 25. NORTH AMERICAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2021-2028 ($ MILLION)
  • 26. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 27. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY TYPE , 2021-2028 ($ MILLION)
  • 28. EUROPEAN KIDNEY CANCERMARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2021-2028 ($ MILLION)
  • 29. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 30. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2021-2028 ($ MILLION)
  • 31. ASIA-PACIFIC ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 32. ASIA-PACIFIC ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY TYPE , 2021-2028 ($ MILLION)
  • 33. ASIA-PACIFIC ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2021-2028 ($ MILLION)
  • 34. ASIA-PACIFIC ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 35. ASIA-PACIFIC ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2021-2028 ($ MILLION)
  • 36. REST OF THE WORLD ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 37. REST OF THE WORLD KIDNEY CANCERMARKET RESEARCH AND ANALYSIS BY TYPE , 2021-2028 ($ MILLION)
  • 38. REST OF THE WORLD ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2021-2028 ($ MILLION)
  • 39. REST OF THE WORLD ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 40. REST OF THE WORLD ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY THERAPY0, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL ARTIFICIAL TEARS MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL ARTIFICIAL TEARS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL ARTIFICIAL TEARS MARKET, 2022-2028 (%)
  • 4. GLOBAL ARTIFICIAL TEARS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL CELLULOSE DERIVED ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL GLYCERINE DERIVED MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL WILM'S TUMOUR CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL OTHER ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL ARTIFICIAL TEARS MARKET SHARE BY DELIVERY METHOD, 2021 VS 2028 (%)
  • 10. GLOBAL EYE DROPS ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL OINTMENTS ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL OTHER ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL ARTIFICIAL TEARS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 14. GLOBAL ARTIFICIAL TEARS DRY EYES TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL ARTIFICIAL TEARS CONTACT LENSES MOISTURE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL ARTIFICIAL TEARS MAGNETIC RESONANCE IMAGING (MRI) MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL ARTIFICIAL TEARS ULTRASOUND MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL ARTIFICIAL TEARS MARKET SHARE BY THERAPY METHOD, 2021 VS 2028 (%)
  • 19. GLOBAL ARTIFICIAL TEARS IMMUNOTHERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. GLOBAL ARTIFICIAL TEARS CHEMOTHERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 21. GLOBAL ARTIFICIAL TEARS RADIATION THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 22. GLOBAL ARTIFICIAL TEARS CRYOTHERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 23. GLOBAL ARTIFICIAL TEARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 24. US ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. CANADA ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. UK ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. FRANCE ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. GERMANY ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. ITALY ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. SPAIN ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. REST OF EUROPE ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. INDIA ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. CHINA ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 34. JAPAN ARTIFICIAL TEARS MARKET SIZE, 2021-2028 ($ MILLION)
  • 35. SOUTH KOREA KIDNEY CANCERMARKET SIZE, 2021-2028 ($ MILLION)
  • 36. REST OF ASIA-PACIFIC KIDNEY CANCERMARKET SIZE, 2021-2028 ($ MILLION)
  • 37. REST OF THE WORLD KIDNEY CANCERMARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026492

Global Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose Derived, Glycerin Derived, Oil Based Emulsion Tears, and Polyethylene Glycol and Propylene Glycol-Based Tears), by Delivery Method (Eye Drops, Ointments), by Application (Dry Eyes Treatment, Contact Lenses Moisture) Forecast (2022-2028)

The global artificial tears market is anticipated to grow at a substantial CAGR of 6.2% during the forecast period. The incidence of dry eye syndrome is increasing among people which is driving the growth of the artificial tears market during the forecast period. The prevalence of dry eye was found to be maximum in the elderly. According to Frontiers Media S.A., dry eye symptoms happened in 54.3% of adult patients.

The global artificial tears market is segmented based on types, delivery methods, and applications. Based on types, the market is further diversified as cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, and polyethylene glycol and propylene glycol-based tears. Based on the delivery method, the market is bifurcated into eye drops and ointments. Based on the application, the market is segmented into dry eyes treatment and contact lenses moisture.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The market in the European region is growing during the forecast period. The increasing usage of advanced eye drops in the European region is driving the artificial tears market growth during the forecast. For instance, in January 2022, Alcon launched Systane artificial tear drops in Europe. European dry eye products portfolio includes Systane Complete Preservative-Free Lubricant Eye Drop, available in an easy-to-use, multi-dose bottle.

The major companies serving the global Artificial Tears market include AbbVie Inc., Bayer Pharma AG, Merck & Co., GlaxoSmithKline Plc, and Pfizer Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2020, Alcon introduced Systane Hydration Preservative-Free (PF), the latest addition to the #1 doctor recommended Systane Family of Products, at the SECO International 2020 meeting (#SECO2020). Systane Hydration PF Lubricant Eye Drops are a new preservative-free option for dry eye sufferers with sensitive eyes and those in need of long-lasting relief. It is used as a protectant against further irritation and to relieve dryness in the eye.

Research Methodology

The market study of the global pharmaceutical filtration market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Artificial Tears Market Research and Analysis by Type.

2. Global Artificial Tears Market Research and Analysis by Delivery Method.

3. Global Artificial Tears Market Research and Analysis by Application.

The Report Covers:

  • Comprehensive Research Methodology of the global pharmaceutical filtration market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global pharmaceutical filtration market.
  • Insights about market determinants that are stimulating the global pharmaceutical filtration market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Artificial Tears Market
  • Recovery Scenario of Global Artificial Tears Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bausch Health Companies Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bayer Pharma AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Merck & Co.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Johnson & Johnson Services
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Teva Pharmaceuticals Industries, Ltd.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis
  • 3.8. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Artificial Tears Market by Type
    • 4.1.1. Cellulose Derived
    • 4.1.2. Glycerine Derived
    • 4.1.3. Oil Based Emulsion Tears
    • 4.1.4. Polyethylene Glycol And Propylene Glycol-Based Tears
  • 4.2. Global Artificial Tears Market by Delivery Method
    • 4.2.1. Eye Drops
    • 4.2.2. Ointments
  • 4.3. Global Artificial Tears Market by Application
    • 4.3.1. Dry Eyes Treatment
    • 4.3.2. Contact Lenses Moisture

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profile

  • 6.1. Akorn Operating Company LLC
  • 6.2. Alcon Vision LLC
  • 6.3. Allergan Plc
  • 6.4. Aura Labs Ltd.
  • 6.5. Bausch Health Companies Inc.
  • 6.6. Bausch & Lomb Inc.
  • 6.7. Carl Zeiss AG
  • 6.8. Essilor International
  • 6.9. Hoya Corp.
  • 6.10. Nicox S.A.
  • 6.11. Novartis International AG
  • 6.12. OCuSOFT Inc.
  • 6.13. Pfizer, Inc.
  • 6.14. ROHTO Pharmaceutical Co., Ltd.
  • 6.15. Sanofi S.A.
  • 6.16. Santen AG
  • 6.17. Similasan Corp.
  • 6.18. Topcon Corp.
  • 6.19. URSAPHARM Arzneimittel GmbH